Search research articles
Contact Us
Filters
Showing results (101-110 of 120) with videos related to
Page
of 12
Sort By:
Journal of Clinical Medicine
|
October 29, 2025
Association Between Hyponatremia and Mortality and Readmission in Multimorbid Older Adults-A Cohort Study
Seraina Netzer, Viktoria Gastens, Benoît Boland, et al.
CMAJ Open
|
September 19, 2023
Patient and public involvement in pragmatic trials: online survey of corresponding authors of published trials
Shelley Vanderhout, Pascale Nevins, Stuart G Nicholls, et al.
Journal of the American Geriatrics Society
|
April 1, 2025
Impact of Discontinuation of Fall-Risk-Increasing Drugs on Falls in Multimorbid Older Patients With Polypharmacy
Namiko A Goto, Dayna A M van Heel, Lauren Dautzenberg, et al.
Plos One
|
April 11, 2022
Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study
Paola Salari, Cian O'Mahony, Séverine Henrard, et al.
Revue Medicale Suisse
|
March 15, 2014
[Why, when and how to monitor new oral anticoagulants]
Anne Tamigniau, Jonathan Douxfils, Jean-Baptiste Nicolas, et al.
Drugs & Aging
|
May 6, 2024
Measuring Quality of Life in Deprescribing Trials: A Scoping Review
Wade Thompson, Carina Lundby, Adam Bleik, et al.
Frontiers in Pharmacology
|
February 5, 2024
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers
Hélène Thirot, David Fage, Antonia Leonhardt, et al.
BMJ (Clinical Research Ed.)
|
June 17, 2025
Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis
Dena Zeraatkar, Sumanth Kumbargere Nagraj, Michael Ling, et al.
Expert Review of Clinical Pharmacology
|
May 13, 2024
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks
Emily G McDonald, Carina Lundby, Wade Thompson, et al.
JAMA Network Open
|
March 3, 2025
Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians
Vladyslav Shapoval, Marie de Saint Hubert, Perrine Evrard, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 120) with videos related to
Sort By:
Page
of 12
Journal of Clinical Medicine
|
October 29, 2025
Association Between Hyponatremia and Mortality and Readmission in Multimorbid Older Adults-A Cohort Study
Seraina Netzer, Viktoria Gastens, Benoît Boland, et al.
CMAJ Open
|
September 19, 2023
Patient and public involvement in pragmatic trials: online survey of corresponding authors of published trials
Shelley Vanderhout, Pascale Nevins, Stuart G Nicholls, et al.
Journal of the American Geriatrics Society
|
April 1, 2025
Impact of Discontinuation of Fall-Risk-Increasing Drugs on Falls in Multimorbid Older Patients With Polypharmacy
Namiko A Goto, Dayna A M van Heel, Lauren Dautzenberg, et al.
Plos One
|
April 11, 2022
Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study
Paola Salari, Cian O'Mahony, Séverine Henrard, et al.
Revue Medicale Suisse
|
March 15, 2014
[Why, when and how to monitor new oral anticoagulants]
Anne Tamigniau, Jonathan Douxfils, Jean-Baptiste Nicolas, et al.
Drugs & Aging
|
May 6, 2024
Measuring Quality of Life in Deprescribing Trials: A Scoping Review
Wade Thompson, Carina Lundby, Adam Bleik, et al.
Frontiers in Pharmacology
|
February 5, 2024
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers
Hélène Thirot, David Fage, Antonia Leonhardt, et al.
BMJ (Clinical Research Ed.)
|
June 17, 2025
Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis
Dena Zeraatkar, Sumanth Kumbargere Nagraj, Michael Ling, et al.
Expert Review of Clinical Pharmacology
|
May 13, 2024
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks
Emily G McDonald, Carina Lundby, Wade Thompson, et al.
JAMA Network Open
|
March 3, 2025
Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians
Vladyslav Shapoval, Marie de Saint Hubert, Perrine Evrard, et al.
Page
of 12